Literature DB >> 6330849

Identification of an antigenic site in the neutralization of type 3 poliovirus.

P D Minor, D M Evans, G C Schild, M Ferguson, J W Almond.   

Abstract

Antigenic mutants of type 3 poliovirus were obtained by picking plaques formed in the presence of neutralizing monoclonal antibodies. All the mutants were clustered into a single operationally defined antigenic site based on their reactions with a panel of antibodies. Most of the mutations were shown to be located in the virion protein VP1 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and oligonucleotide mapping, and 15 of 16 mutants had single-point mutations in a region of VP1 encompassing only eight amino acids, a finding suggesting that this is a major target for the neutralization of the virus. Whereas other areas may also be required, it is likely that this region is a necessary component of a vaccine of any kind.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330849     DOI: 10.1093/clinids/6.supplement_2.s516

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  3 in total

1.  A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.

Authors:  A Zurbriggen; R S Fujinami
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

2.  Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.

Authors:  A Zurbriggen; C Thomas; M Yamada; R P Roos; R S Fujinami
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant.

Authors:  A Zurbriggen; M Yamada; C Thomas; R S Fujinami
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.